CFGS
HAE icon

Concourse Financial Group Securities’s Haemonetics HAE Stock Holding History

Concourse Financial Group Securities’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$323 – 2299
2024
Q2 		$330 Hold
4
– – ﹤0.01% 2227
2024
Q1 		$341 Hold
4
– – ﹤0.01% 2240
2023
Q4 		$342 Buy
+4
New +$346 ﹤0.01% 2215
2020
Q3 		– Sell
-39
Closed -$3.41K – 2195
2020
Q2 		$3K Sell
39
-3
-7% -$303 ﹤0.01% 1825
2020
Q1 		$4K Sell
42
-126
-75% -$13.7K ﹤0.01% 1721
2019
Q4 		$19K Buy
168
+17
+11% +$2.06K ﹤0.01% 1263
2019
Q3 		$19K Buy
+151
New +$19.2K ﹤0.01% 977

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Concourse Financial Group Securities's HAE Position: Q3 2024 in Review

Concourse Financial Group Securities sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 4 shares — an estimated $323 sold.

Concourse Financial Group Securities first reported a position in HAE in Q3 2019 and held it in 7 quarters. The position peaked at $19K in Q4 2019. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Concourse Financial Group Securities reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 4 Haemonetics shares in Q3 2024, an estimated $323.
  • Concourse Financial Group Securities first reported a position in Haemonetics in Q3 2019 and held it in 7 quarters.
  • Concourse Financial Group Securities's Haemonetics position peaked at $19K in Q4 2019.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Concourse Financial Group Securities's 13F filing for Q3 2024, filed 10 Oct 2024.